VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CRDF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CRDFCardiff Oncology, Inc.
$1.12$86M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCRDFQuarterly Balance Sheet

Cardiff Oncology, Inc. (CRDF) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Cardiff Oncology, Inc. (CRDF) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

CRDF Balance Sheet

Quarterly statement

CRDF Balance Sheet

Cardiff Oncology, Inc. (CRDF) balance sheet — 18-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets35.59M47.34M60.13M61.8M73.7M82.71M95.05M59.33M62.25M69.99M77.41M83.91M92.73M101.75M111.28M119.75M127.41M135.81M146.13M137.77M
Cash & Short-Term Investments34.52M46.06M58.3M60.59M70.96M79.89M91.75M57.67M60.32M67.19M74.82M81.36M89.43M96.97M105.27M114.3M122.01M129.36M140.82M134.05M
Cash Only9.2M8.54M17.47M10.13M10.78M24.09M51.47M13.04M25.5M18.66M21.66M15.23M19.37M15.02M16.35M18.72M20.96M20.05M11.94M13.16M
Short-Term Investments25.32M37.51M40.83M50.46M60.17M55.79M40.28M44.63M34.82M48.53M53.17M66.13M70.06M81.95M88.92M95.59M101.04M109.31M128.88M120.88M
Accounts Receivable189K191K182K254K526K405K773K618K451K393K288K198K161K676K771K650K551K447K535K395K
Days Sales Outstanding166.25409.3982.53299350.09486.33423.75298.02235.6151.15143.31117.12352.63784.52510.67594.04499597.16321.65376.02
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets01.09M1.64M02.21M2.42M2.54M1.05M1.48M2.41M2.3M2.34M3.14M4.11M5.25M00000
Total Non-Current Assets1.74M1.83M1.76M1.98M2.04M2.1M2.14M3.56M3.81M4.05M4.22M4.55M4.72M4.8M4.91M3.88M3.85M3.4M3.42M3.54M
Property, Plant & Equipment810K986K1.21M1.43M1.64M1.84M2.07M2.3M2.53M2.77M2.95M3.16M3.33M3.44M3.52M3.69M3.66M3.21M3.18M3.4M
Fixed Asset Turnover0.12x0.04x0.18x0.08x0.07x0.06x0.07x0.07x0.06x0.07x0.05x0.04x0.03x0.02x0.04x0.03x0.03x0.02x0.04x0.04x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets927K844K549K549K401K257K69K1.27M1.27M1.27M1.28M1.39M1.39M1.36M1.39M184K185K188K239K143K
Total Assets37.33M49.17M61.88M63.78M75.74M84.81M97.19M62.9M66.05M74.04M81.64M88.45M97.45M106.55M116.19M123.63M131.26M139.2M149.54M141.31M
Asset Turnover0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Asset Growth %-50.71%-42.02%-36.33%1.41%14.67%14.55%19.05%-28.89%-32.22%-30.51%-29.74%-28.45%-25.75%-23.46%-22.3%-12.51%-8.68%7.43%11%258.2%
Total Current Liabilities10.8M14.46M16.39M14.71M16.67M13.29M13.43M12.53M12.52M11.84M10.44M9.02M9.12M8.15M7.81M8.24M8.48M6.66M6.56M5.04M
Accounts Payable3.99M5.48M8.09M2.44M6.01M3.63M4.82M4.64M5.11M5.19M1.97M2.18M2.94M2.91M1.96M1.43M1.52M1.26M1.44M396K
Days Payables Outstanding----37.87--46.534.46K3.19K1.85K2.2K--------
Short-Term Debt00000000000000000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities04.53M2.43M3.14M2.25M1.3M2.75M1.99M4.92M1.23M2.74M2.46M2.17M983K01.62M1.31M878K1.48M42K
Current Ratio3.30x3.27x3.67x4.20x4.42x6.22x7.08x4.74x4.97x5.91x7.41x9.30x10.16x12.49x14.25x14.52x15.02x20.38x22.28x27.32x
Quick Ratio3.30x3.27x3.67x4.20x4.42x6.22x7.08x4.74x4.97x5.91x7.41x9.30x10.16x12.49x14.25x14.52x15.02x20.38x22.28x27.32x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities00102K284K464K640K813K979K1.14M1.3M1.46M1.61M1.75M1.9M2.04M2.17M2.31M2.44M2.57M2.73M
Long-Term Debt00000000000000000000
Capital Lease Obligations00102K284K464K640K813K979K1.14M1.3M1.46M1.61M1.75M1.9M2.04M2.17M2.31M2.44M2.57M2.69M
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities000000000000000000035K
Total Liabilities10.8M14.46M16.5M14.99M17.13M13.93M14.24M13.5M13.66M13.14M11.9M10.63M10.88M10.05M9.85M10.42M10.79M9.1M9.13M7.77M
Total Debt457K646K832K1.01M1.19M1.36M1.52M1.69M1.84M2M2.15M2.29M2.44M2.58M2.71M2.85M2.98M3.1M3.12M3.29M
Net Debt-8.74M-7.9M-16.64M-9.13M-9.6M-22.74M-49.95M-11.35M-23.66M-16.66M-19.51M-12.94M-16.93M-12.44M-13.63M-15.87M-17.99M-16.95M-8.82M-9.88M
Debt / Equity0.02x0.02x0.02x0.02x0.02x0.02x0.02x0.03x0.04x0.03x0.03x0.03x0.03x0.03x0.03x0.03x0.02x0.02x0.02x0.02x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--------------------
Total Equity26.53M34.71M45.39M48.79M58.61M70.88M82.95M49.39M52.39M60.89M69.74M77.83M86.58M96.5M106.34M113.21M120.47M130.1M140.42M133.54M
Equity Growth %-54.73%-51.03%-45.28%-1.22%11.87%16.39%18.94%-36.54%-39.49%-36.9%-34.42%-31.26%-28.13%-25.83%-24.27%-15.22%-13.28%4.23%9.57%298.37%
Book Value per Share0.390.510.680.730.881.491.741.051.171.361.561.741.942.162.382.612.783.013.463.38
Total Shareholders' Equity26.53M34.71M45.39M48.79M58.61M70.88M82.95M49.39M52.39M60.89M69.74M77.83M86.58M96.5M106.34M113.21M120.47M130.1M140.42M133.54M
Common Stock7K7K7K7K7K7K7K5K5K4K4K4K4K4K4K4K4K4K4K4K
Retained Earnings-451.61M-442.38M-430.03M-422.81M-411.56M-397.61M-384.18M-372.39M-360.54M-348.76M-339.54M-330.2M-320.47M-309.32M-298.1M-289.83M-281.26M-270.81M-259.81M-250.36M
Treasury Stock00000000000000000000
Accumulated OCI-62K-49K50K50K17K27K34K82K-97K-132K-67K-407K-431K-76K-395K-779K-982K-748K-142K16K
Minority Interest00000000000000000000